StemSight is a pioneering brand on a mission to revolutionize eye therapies and restore sight to patients. What sets StemSight apart is their team of dedicated scientists who are committed to making a difference. StemSight's story began in 2005 when Professor Outi Hovatta established the state-of-the-art research facility Regea in Tampere, Finland, to develop advanced cellular medicines.

Heli Skottman, a prominent researcher, joined Outi and later formed the Eye Regeneration Group, focusing on using stem cells to treat eye conditions. StemSight's breakthrough came in responding to a plea from cornea clinicians in the early 2010s to find a cure for limbal stem cell deficiency. Through years of research and refinement, StemSight developed innovative methods for differentiating and culturing stem cells.

In 2021, driven by their unwavering purpose, the scientists behind StemSight established the company, bringing their groundbreaking technology closer to transforming the lives of countless patients. With StemSight, hope for restored vision becomes a reality